Bilexa 200 Inhalation Capsule (25mcg+200mcg) 10pcs

Uses of Bilexa 200 Inhalation Capsule

• Asthma
• Chronic obstructive pulmonary disease (COPD)

How does Bilexa 200 Inhalation Capsule work?

Bilexa 200 Inhalation Capsule is a combination of fluticasone furoate and vilanterol. Fluticasone furoate works by blocking the production of certain chemicals in the body thatreathing easier.

Side Effects of Bilexa 200 Inhalation Capsule

Common side effects of COPD include nasopharyngitis, upper respiratory tract infection, headache, and oral candidiasis. For asthma, common side effects include nasopharyngitis, oral candidiasis, headache, and influenza.

Quick Suggestions:

• The Bilexa 200 Inhalation Capsule is designed to reduce inflammation in the lungs, offering long-term treatment for asthma and preventing disease progression.
• It is not suitable for managing ongoing asthma attacks; for sudden breathing difficulties, rely on your rescue inhaler.
• Learn the proper technique for using metered dose inhalers (MDI) and dry powder inhalers (DPI).
• Gargle with warm water after each inhalation to prevent fungal infections in the mouth and throat.
• Take Bilexa 200 Inhalation Capsulee at the same time daily to prevent asthma attacks.
• Avoid unnecessary opening and closing of the cover to retain the medication.
• Never exhale into the mouthpiece.
• The absorption of minuscule amounts into the bloodstream after inhalation makes serious side effects like weight gain unlikely.

Indication

Bilexa Inhalation Capsule is indicated for the long-term, once-daily maintenance treatment of airflow obstruction and for reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). It is also used once daily for the treatment of asthma in patients aged 18 years and older. The composition includes Vilanterol 25 mcg (as Vilanterol Trifenatate INN) and Fluticasone Furoate INN 100 mcg or 200 mcg, depending on the variant.

Pharmacology

Vilanterol Trifenatate is a selective, long-acting beta-2 agonist, and Fluticasone Furoate is a corticosteroid with glucocorticoid activity. The combination works to provide therapeutic effects in the treatment of COPD and asthma by addressing airway obstruction and inflammation.

Dosage & Administration of Bilexa 200 Inhalation Capsule

Dosage and administration involve oral inhalation, and the capsule should not be swallowed. The recommended dosage for maintenance treatment of COPD is 1 inhalation of 25/100 mcg once daily, and for asthma, it is 1 inhalation of 25/100 mcg or 25/200 mcg once daily.

Interaction

The inhalation capsule may interact with other medications, and caution is advised with strong cytochrome P450 3A4 inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, beta-blockers, and diuretics.

Contraindications

Contraindications include primary treatment of status asthmaticus or acute episodes of COPD or asthma requiring intensive measures and severe hypersensitivity to milk proteins or any ingredients.

Pregnancy & Lactation

The use of Bilexa Inhalation Capsule during pregnancy and lactation requires further data. 

Precautions & Warnings

Precautions include the risk of serious asthma-related events with LABA monotherapy, avoidance of acutely deteriorating COPD or asthma, and careful monitoring for systemic corticosteroid effects in patients with hepatic impairment.

Storage Conditions

Storage conditions involve avoiding direct sunlight or heat, storing in a cool and dry place, and keeping it away from the eyes.